We specialize in analyzing SEER-Medicare data, not only for solid tumors but also for lymphoma and leukemia (and eventually, myeloma). We have published our SEER Medicare work in a variety of journals, including Blood, BMC Cancer, Annals of Oncology, American Journal of Hematology, and Pharmacoeconomics. In addition, we have presented our findings at meetings for the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and the San Antonio Breast Cancer Symposium (SABCS).
We created a summary of all of the SEER Medicare publications through 2020, which is available at our SEER Medicare Publications Summary page. See below for selected publications using SEER-Medicare data.
Griffiths RI, O’Malley CD, Herbert RJ, Danese MD. Misclassification of Incident Conditions Using Claims Data: Impact of Varying the Period Used to Exclude Pre-Existing Disease. (Submitted).
Griffiths RI, Gleeson ML, Valderas JM, Danese MD. Undiagnosed Comorbidity in Older Women with Breast Cancer: Incidence, Risk Factors, and Outcomes. (Submitted)
Griffiths RI, Danese MD, Gleeson ML, Valderas JM. Epidemiology and Outcomes of Undiagnosed Diabetes in Older Women Diagnosed With Breast Cancer: An Observational Cohort Study Based on SEER-Medicare. (Submitted).
Griffiths RI, Lindquist KJ, O’Malley CD, Gleeson ML, Duryea JL, Valderas JM, Danese MD. Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors. (Submitted).